Researchers have been able to find that high levels of a protein can be considered as early sign of the developing Alzheimer and a simple blood test would be capable of making a prediction almost up to ten years prior to a person’s developing the condition.
Scientists are of the suggestion that levels of the protein that are named as clusterin rise ”many years” prior to symptoms of Alzheimer's disease firsts making its appearance.
An early test for the condition possibly will permit those patients to have early treatment and bring improvements in their everyday life, so as to minimize the impact of the disease.
The study, which had been carried out by the Institute of Psychiatry at King's College London, also found that incredibly high levels of the protein might have an association with faster and severe memory loss.
Patient groups said that the prospect of a blood test for Alzheimer's disease was the sacred grail' for researchers in this region and the most modern findings bring this a step somewhat closer.
Alzheimer's disease is the most ordinary variety of dementia in Britain and has an effect on around 500,000 people. The figure is anticipated to double by 2050 as the populace ages.
Related News
- Eye Test Could Diagnose Alzheimer’s Disease
- Changes Needed in Alzheimer’s Treatment Approach
- Clusterin Levels Cannot Detect Alzheimer's
- Alzheimer's treatment 'could be developed in five years'
- Alzheimer and Down syndrome are Inter-related: Major Research says
- People with Diabetes Risk More Likely to Develop Alzheimer's Plaques
- Alzheimer’s could be detected early by ‘Biomarkers’
